Arjun Mittra

Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

Naoko Takebe, Abdul Rafeh Naqash, Geraldine O’Sullivan Coyne et al. · Clinical Cancer Research · 2021 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Talal El Zarif, Amin H. Nassar, Elio Adib et al. · Journal of Clinical Oncology · 2023 · 69 citations · Full text

Life Sciences, Immunology, Oncology +17

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

Talal El Zarif, Amin H. Nassar, Gregory R. Pond et al. · JNCI Journal of the National Cancer Institute · 2023 · 55 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis

Vijaya Bharti, Reese Watkins, Amrendra Kumar et al. · Cell Reports · 2022 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +14

Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus

Dana Haddad, Nanhai G. Chen, Qian Zhang et al. · Journal of Translational Medicine · 2011 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +14